KA/EN
Register
Medicines reference
Search
Search
Product

CitoDerm

Favourites

Chlorhexidine · JSC NPF Ekoprom

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
42.4 mg/ml medicated shampoo with chlorhexidine, Solution · Cat Cat 0.5–1 ml/kg
Wet the coat thoroughly. Apply 0.5-1 ml/kg, distribute evenly and massage until foam forms. Avoid the eyes and prevent licking. Rinse thoroughly after 5-7 minutes. Use every 3-7 days according to severity for a 3-4 week course. Do not use in hypersensitivity. Pregnancy, lactation and young animals require veterinary supervision. If salivation, lacrimation or skin irritation occurs, rinse the product off and provide symptomatic treatment if needed.
 · Every 3-7 days for 3-4 weeks		 Every 3-7 days for 3-4 weeks Georgia Yes, veterinary
In force until 21 Mar 2029
Veterinary (National Food Agency)
In the register: ციტოდერმი 42.4 მგ/მლ, 200 მლ ძაღლისა და კატისთვის
№ 000573
Verified on: 23 Oct 2026
42.4 mg/ml medicated shampoo with chlorhexidine, Solution · Dog Dog 0.5–1 ml/kg
Wet the coat thoroughly. Apply 0.5-1 ml/kg, distribute evenly and massage until foam forms. Avoid the eyes and prevent licking. Rinse thoroughly after 5-7 minutes. Use every 3-7 days according to severity for a 3-4 week course. Do not use in hypersensitivity. Pregnancy, lactation and young animals require veterinary supervision. If salivation, lacrimation or skin irritation occurs, rinse the product off and provide symptomatic treatment if needed.
 · Every 3-7 days for 3-4 weeks		 Every 3-7 days for 3-4 weeks Georgia Yes, veterinary
In force until 21 Mar 2029
Veterinary (National Food Agency)
In the register: ციტოდერმი 42.4 მგ/მლ, 200 მლ ძაღლისა და კატისთვის
№ 000573
Verified on: 23 Oct 2026
Details: pack, label wording, sources, registration

CitoDerm 42.4 mg/ml medicated shampoo with chlorhexidine, Solution

200 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention
6.4/10
Situational / acceptable
vetman assessment

CitoDerm

42.4 mg/ml medicated shampoo with chlorhexidine, 200 ml for dogs and cats
Assessed clinical scopeDog · Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention · On the skin
Care settingVeterinary-selected whole-body or local rinse-off treatment after dermatologic diagnosis; home application is possible with exact weighing, contact-time and licking/eye control
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000573 · Verified on 23 Oct 2026

A locally authorised chlorhexidine shampoo with meaningful canine class evidence for superficial bacterial and selected Malassezia disease, but no exact-product outcomes and a label far broader than the evidence. It is a useful diagnosis-led topical option, not stand-alone validation for deep infection, dermatophytosis, allergy or interdigital furunculosis.

Regulatory and scientific credibility6.5/10

The exact 200 ml dog/cat product has current Georgian authorisation and a reproducible manufacturer instruction, but the instruction has a blank registration field and no public exact-product regulator assessment. Exact EU/GB/US authorisation is absent; regulated chlorhexidine shampoos are formulation controls only.

Clinical efficacy5.5/10

Independent canine trials and ISCAID/WAVD guidance support 2-4% chlorhexidine shampoos for superficial bacterial and selected Malassezia disease. No exact CitoDerm trial was found, its contact time differs, and evidence does not validate the full deep-pyoderma, dermatophyte, atopy/flea or interdigital-furunculosis breadth.

Safety and tolerability7.0/10

Rinse-off chlorhexidine has low systemic exposure and chiefly local labelled reactions, but exact quantified target-animal, reproductive and repeat-course safety data are absent. Ocular, mucosal, ear/tympanic, ingestion, contact-allergy and damaged-tissue exposure require active control.

Clinical practicality6.5/10

The measured 0.5-1 ml/kg range, 5-7-minute contact and finite 3-4-week course are clear, and 200 ml is workable for many dogs. Whole-body wetting, massage, rinsing/drying every 3-7 days, variable coat demand and coordination with other topical products still create material workload.

Full-course cost-effectiveness-

Current Georgian per-course price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Complete-label boundary: this score includes superficial and deep pyoderma, bacterial/fungal/mixed and atopic lesions, Malassezia/dermatophyte wording, flea/interdigital dermatitis, interdigital cystic folliculitis and post-clipping prevention. Stronger superficial-disease evidence is not scored alone.
  • Evidence boundary: canine 2-4% chlorhexidine studies support superficial bacterial and selected Malassezia disease, but no exact CitoDerm trial validates its 5-7-minute contact, excipients or complete breadth. Deep pyoderma and interdigital furunculosis commonly need systemic/source-control care.
  • Diagnostic boundary: use cytology for bacterial/yeast disease; culture rods, deep/recurrent/unusual or failing infection; perform appropriate fungal testing; and investigate allergy, fleas/mites, endocrine/immune disease, foreign material and conformational causes before repeating treatment.
  • Exact regimen: wet the coat; apply 0.5-1 ml/kg; distribute and massage to foam; prevent eye contact and licking; rinse thoroughly after 5-7 minutes, comb and dry. Repeat every 3-7 days according to severity for 3-4 weeks; do not substitute comparator contact schedules.
  • Response/escalation: reassess superficial bacterial disease by 2-3 weeks. Systemic illness, pain, draining tracts, deep or rapidly progressive lesions, treatment failure or recurrence requires prompt re-evaluation, source control and systemic/other targeted therapy when indicated.
  • Disease distinction: dermatophytosis and Malassezia dermatitis are not synonyms despite the label parenthesis. Dermatophyte cure needs disease-specific testing, whole-coat/environment/in-contact control and often validated topical plus systemic therapy; atopy and flea allergy require cause control.
  • External skin/coat only: avoid eyes/conjunctiva, mouth, mucosa, ear canals, body cavities and deep ulcerated tissue. Chlorhexidine can seriously injure the eye and middle/inner ear; rinse accidental exposure immediately and urgently assess persistent ocular, hearing or vestibular signs.
  • Stop and rinse for hypersalivation, lacrimation, erythema, pruritus or worsening irritation. Consider hypersensitivity to chlorhexidine, propolis, fragrance or surfactants. Pregnancy, lactation and young animals require veterinary supervision; exact reproductive safety data are absent.
  • Combination boundary: adjunct treatment may be necessary, but exact compatibility was not studied. Anionic soaps/detergents can reduce chlorhexidine activity and frequent shampooing can alter some topical ectoparasiticide duration; deliberately sequence products and avoid casual stacking.
  • Practical/handler boundary: at the label range, 200 ml supplies 200-400 kg-total bodyweight per application, but coat and lesion extent change real use. Wear gloves for repeated treatment or dermatophytosis, avoid eyes/mouth, wash hands and disinfect equipment/environment.
Assessment sources
  1. CitoDerm GE register2026
  2. Ekoprom CitoDerm
  3. Clorexivet 4% control2026
  4. Malaseb VMD control2025
  5. ISCAID canine pyoderma 20252025
  6. WAVD Malassezia2020
  7. Chlorhexidine pyoderma RCT2010
  8. 4% chlorhexidine canine trial2015
  9. WAVD dermatophytosis2017
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention
5.6/10
Weak evidence support
vetman assessment

CitoDerm

42.4 mg/ml medicated shampoo with chlorhexidine, 200 ml for dogs and cats
Assessed clinical scopeCat · Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention · On the skin
Care settingVeterinary-selected whole-body or local rinse-off treatment after dermatologic diagnosis; home application is possible with exact weighing, contact-time and licking/eye control
vetman score 5.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000573 · Verified on 23 Oct 2026

A locally authorised feline shampoo with a clear regimen but no exact outcome programme and sparse direct feline chlorhexidine evidence. Broad infection/allergy claims, bathing burden and licking/ocular-aural risk make complete-label value weak unless diagnosis and adjunct treatment are explicit.

Regulatory and scientific credibility6.5/10

The exact 200 ml dog/cat product has current Georgian authorisation and a reproducible manufacturer instruction, but the instruction has a blank registration field and no public exact-product regulator assessment. Exact EU/GB/US authorisation is absent; regulated chlorhexidine shampoos are formulation controls only.

Clinical efficacy4.0/10

Exact feline authorisation and a recent different chlorhexidine-combination study provide limited plausibility, but consensus finds topical feline chlorhexidine evidence largely unsubstantiated. Canine trials cannot validate the broad cat label, deep disease, dermatophytosis or allergy claims.

Safety and tolerability6.5/10

Low systemic exposure is favourable, but feline exact safety outcomes are absent and grooming/ingestion plus ocular or aural transfer are more consequential. Salivation, lacrimation, irritation, component allergy and restraint stress require prevention and prompt rinsing.

Clinical practicality5.5/10

The regimen is explicit, but repeated whole-body wetting, restraint, 5-7-minute licking prevention, thorough rinsing and drying are commonly harder in cats. Cooperation, welfare and accidental ingestion can limit adherence; a local cotton-pad technique does not remove diagnostic or environmental work.

Full-course cost-effectiveness-

Current Georgian per-course price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Complete-label boundary: this score includes superficial and deep pyoderma, bacterial/fungal/mixed and atopic lesions, Malassezia/dermatophyte wording, flea/interdigital dermatitis, interdigital cystic folliculitis and post-clipping prevention. Stronger superficial-disease evidence is not scored alone.
  • Feline evidence boundary: exact local authorisation does not equal demonstrated outcomes. Consensus finds topical feline chlorhexidine evidence sparse; a recent different chlorhexidine/Ophytrium study and canine trials cannot validate CitoDerm or its full cat label.
  • Diagnostic boundary: use cytology for bacterial/yeast disease; culture rods, deep/recurrent/unusual or failing infection; perform appropriate fungal testing; and investigate allergy, fleas/mites, endocrine/immune disease, foreign material and conformational causes before repeating treatment.
  • Exact regimen: wet the coat; apply 0.5-1 ml/kg; distribute and massage to foam; prevent eye contact and licking; rinse thoroughly after 5-7 minutes, comb and dry. Repeat every 3-7 days according to severity for 3-4 weeks; do not substitute comparator contact schedules.
  • Response/escalation: reassess superficial bacterial disease by 2-3 weeks. Systemic illness, pain, draining tracts, deep or rapidly progressive lesions, treatment failure or recurrence requires prompt re-evaluation, source control and systemic/other targeted therapy when indicated.
  • Disease distinction: dermatophytosis and Malassezia dermatitis are not synonyms despite the label parenthesis. Dermatophyte cure needs disease-specific testing, whole-coat/environment/in-contact control and often validated topical plus systemic therapy; atopy and flea allergy require cause control.
  • External skin/coat only: avoid eyes/conjunctiva, mouth, mucosa, ear canals, body cavities and deep ulcerated tissue. Chlorhexidine can seriously injure the eye and middle/inner ear; rinse accidental exposure immediately and urgently assess persistent ocular, hearing or vestibular signs.
  • Stop and rinse for hypersalivation, lacrimation, erythema, pruritus or worsening irritation. Consider hypersensitivity to chlorhexidine, propolis, fragrance or surfactants. Pregnancy, lactation and young animals require veterinary supervision; exact reproductive safety data are absent.
  • Combination boundary: adjunct treatment may be necessary, but exact compatibility was not studied. Anionic soaps/detergents can reduce chlorhexidine activity and frequent shampooing can alter some topical ectoparasiticide duration; deliberately sequence products and avoid casual stacking.
  • Cat practicality/handler boundary: assess whether repeated whole-body restraint, wetting, 5-7-minute contact, rinsing and drying are humane and achievable. Prevent grooming/ingestion until fully rinsed and dry; use gloves for dermatophytosis and clean equipment/environment.
Assessment sources
  1. CitoDerm GE register2026
  2. Ekoprom CitoDerm
  3. Clorexivet 4% control2026
  4. Malaseb VMD control2025
  5. ISCAID canine pyoderma 20252025
  6. WAVD Malassezia2020
  7. Chlorhexidine pyoderma RCT2010
  8. WAVD dermatophytosis2017
  9. Feline chlorhexidine study2025
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Chlorhexidine42.4 mg/ml
Formulation Type
Solution
Administration route
On the skin
Manufacturer
JSC NPF Ekoprom
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1030, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 21 Mar 2029
Veterinary (National Food Agency)
In the register: ციტოდერმი 42.4 მგ/მლ, 200 მლ ძაღლისა და კატისთვის
№ 000573
Verified on: 23 Oct 2026
 EU No
Verified on: 23 Oct 2026
 UK No
Verified on: 23 Oct 2026
 US No
Verified on: 23 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Complete label: bacterial, fungal/mixed and atopic skin lesions, superficial/deep pyoderma, Malassezia/dermatophyte wording, flea/interdigital dermatitis and post-clipping complication prevention. Wet coat; apply 0.5-1 ml/kg; foam; prevent eye contact/licking; rinse after 5-7 minutes; repeat every 3-7 days for 3-4 weeks. Diagnose and treat the underlying disease; broad/deep claims are not equally validated.
DoseSpeciesWeightRouteFrequencySource
0.5–1 ml/kg
Wet the coat thoroughly. Apply 0.5-1 ml/kg, distribute evenly and massage until foam forms. Avoid the eyes and prevent licking. Rinse thoroughly after 5-7 minutes. Use every 3-7 days according to severity for a 3-4 week course. Do not use in hypersensitivity. Pregnancy, lactation and young animals require veterinary supervision. If salivation, lacrimation or skin irritation occurs, rinse the product off and provide symptomatic treatment if needed.
 Cat Any weight On the skin Every 3-7 days for 3-4 weeks
Ekoprom CitoDerm
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
CitoDerm medicated shampoo with chlorhexidine - official manufacturer instruction
Ekoprom official product instruction
0.5–1 ml/kg
Wet the coat thoroughly. Apply 0.5-1 ml/kg, distribute evenly and massage until foam forms. Avoid the eyes and prevent licking. Rinse thoroughly after 5-7 minutes. Use every 3-7 days according to severity for a 3-4 week course. Do not use in hypersensitivity. Pregnancy, lactation and young animals require veterinary supervision. If salivation, lacrimation or skin irritation occurs, rinse the product off and provide symptomatic treatment if needed.
 Dog Any weight On the skin Every 3-7 days for 3-4 weeks
Ekoprom CitoDerm
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
CitoDerm medicated shampoo with chlorhexidine - official manufacturer instruction
Ekoprom official product instruction

Known Contraindications

  • Critical
    Do not use in cases of hypersensitivity to the active substances or to any of the excipients. Exceptionally in dogs with atopy or cats with allergic skin disease.
    Sources: VMD SPC · VMD

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗